retatrutide side effects trial results Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v New Phase 3 retatrutide data

Researchers can verify the result directly at FreedomDiagnosticsTesting.com using accession 2603130115 no involvement from Profound Peptides is required.

Retatrutide influences metabolic markers by reducing HbA1c, improving insulin sensitivity, and lowering fasting glucose

Is this something patients are going to be on forever

Last reviewed: May 2026 Retatrutide is one of the most searched metabolic peptides in Thailand right now, and for good reason

The revised European Working Group on Sarcopenia in Older People, known as EWGSOP2, places low muscle strength at the center of the assessment

Patients who have undergone cholecystectomy (gallbladder removal) can generally use weight loss injections safely, as there is no absolute contraindication to GLP-1 receptor agonist therapy in this population